A covalent inhibitor of K-Ras(G12C) induces MHC class I presentation of haptenated peptide neoepitopes targetable by immunotherapy

Ziyang Zhang(University of California, Berkeley), Charles S. Craik(University of California, San Francisco), Peter J. Rohweder(University of California, San Francisco), Veronica Steri(University of California, San Francisco), Chayanid Ongpipattanakul(University of California, San Francisco), Koli Basu(University of California, San Francisco), Kevan M. Shokat(Howard Hughes Medical Institute), Eli Dugan(Gladstone Institutes), Markus‐Frederik Bohn(University of California, San Francisco), Byron Hann(University of California, San Francisco)
Cancer Cell
September 1, 2022
Cited by 131


Related Papers